Your browser doesn't support javascript.
loading
A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition.
Altintop, Mehlika D; Sever, Belgin; Akalin Çiftçi, Gülsen; Ertorun, Ipek; Alatas, Özkan; Özdemir, Ahmet.
Afiliação
  • Altintop MD; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
  • Sever B; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
  • Akalin Çiftçi G; Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
  • Ertorun I; Department of Medical Biochemistry, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Alatas Ö; Department of Medical Biochemistry, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Özdemir A; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
Arch Pharm (Weinheim) ; 355(9): e2200136, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35606682

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiossemicarbazonas Limite: Animals Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiossemicarbazonas Limite: Animals Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia País de publicação: Alemanha